IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11896645 B1

PDFFull Text
Date of Patent:
Feb. 13, 2024

Filed:

Feb. 17, 2021

Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions

Applicant:

University of the Witwatersrand, Johannesburg, Johannesburg, ZA;

Inventors:

Stefan Franz Thomas Weiss, Johannesburg, ZA;

Boitelo Theresiah Letsolo, Johannesburg, ZA;

Kerrilyn Naidoo, Durban, ZA;

Tyrone Chad Otgaar, Roodepoort, ZA;

Assignee:

UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG, Johannesburg, ZA;

Attorneys:

Casimir Jones SC

Lisa Mueller

Primary Examiner:

Ruixiang Li

Int. Cl.
CPC ...
A61K 38/17 (2006.01); C12N 15/113 (2010.01); C07K 14/705 (2006.01); A61P 17/06 (2006.01); A61P 21/00 (2006.01); A61P 9/10 (2006.01); A61P 39/00 (2006.01); A61P 3/10 (2006.01); A61P 35/04 (2006.01); A61P 19/10 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 38/177 (2013.01); A61K 39/395 (2013.01); A61P 3/10 (2018.01); A61P 9/10 (2018.01); A61P 17/06 (2018.01); A61P 19/10 (2018.01); A61P 21/00 (2018.01); A61P 35/04 (2018.01); A61P 39/00 (2018.01); C07K 14/70546 (2013.01); C07K 16/28 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01);
Abstract

The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cancer and cellular ageing. Particularly, herein is disclosed 37 kDa/67 kDa laminin receptor precursor/high affinity laminin receptor (LRP/LR) and/or a fragment thereof for use in the treatment and/or prevention of cellular ageing.

Find Patent Forward Citations

Loading…